tirzepatide itchy scalp DermDx: Focal Area of Hair Loss Tirzepatide Itching at Injection Site:

As more research emerges and public interest grows, the challenge will be balancing innovation with caution ensuring that the most promising treatments of today dont become the affordability crisis of tomorrow

Even modest weight loss can significantly improve reproductive outcomes

In: Freitas A, Navarro A (eds) Bioinformatics for personalized medicine

2 REDEFINE 2 was a double-blind, randomized, placebo-controlled 68-week phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus placebo, both along with lifestyle intervention in 1,206 adults with type 2 diabetes and either obesity or overweight